UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| REVENUES | ||||
| Total revenues | $ 391,700 | $ 40,400 | $ 973,600 | $ 94,500 |
| OPERATING EXPENSES | ||||
| Cost of revenues | 244,200 | 16,200 | 627,400 | 23,700 |
| Research | 64,800 | 40,600 | 219,700 | 101,500 |
| Product development | 361,900 | 278,900 | 973,300 | 867,000 |
| Sales and marketing | 182,600 | 292,100 | 1,487,800 | 589,600 |
| General and administrative | 2,451,600 | 966,800 | 5,967,400 | 2,922,800 |
| Total operating expenses | 3,305,100 | 1,594,600 | 9,275,600 | 4,504,600 |
| OPERATING LOSS | (2,913,400) | (1,554,200) | (8,302,000) | (4,410,100) |
| OTHER INCOME (EXPENSE): | ||||
| Interest expense, net | (23,800) | (1,900) | (62,300) | (5,800) |
| Total other income (expense) | (23,800) | (1,900) | (62,300) | (5,800) |
| LOSS BEFORE PROVISION FOR INCOME TAXES | (2,937,200) | (1,556,100) | (8,364,300) | (4,415,900) |
| Income taxes | 16,300 | 1,900 | 48,700 | |
| NET LOSS | (2,937,200) | (1,572,400) | (8,366,200) | (4,464,600) |
| Net loss attributable to noncontrolling interest | (332,200) | (404,500) | ||
| Net Loss attributable to MYnd Analytics, Inc. | $ (2,605,000) | $ (1,572,400) | $ (7,961,700) | $ (4,464,600) |
| BASIC AND DILUTED LOSS PER SHARE (in dollars per share): | $ (0.46) | $ (0.62) | $ (1.66) | $ (1.91) |
| WEIGHTED AVERAGE SHARES OUTSTANDING: | ||||
| Basic and Diluted (in shares) | 5,698,523 | 2,535,394 | 4,793,273 | 2,336,283 |
| Neurometric Services [Member] | ||||
| REVENUES | ||||
| Total revenues | $ 65,600 | $ 40,400 | $ 198,700 | $ 94,500 |
| Telepsychiatry Services [Member] | ||||
| REVENUES | ||||
| Total revenues | $ 326,100 | $ 774,900 | ||
| X | ||||||||||
- Definition The aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique. No definition available.
|
| X | ||||||||||
- Definition The expense related to research activities incurred by the entity during the reporting period. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before tax, of income (loss) attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|